BioMotiv, associated with #TheHarringtonProject, and Bristol-Myers Squibb launch their first #biotech after the announcement of their partnership, Anteros Pharmaceuticals, focused on developing new class of drugs for #fibrotic and #inflammatorydiseases. bit.ly/2SkVVrc

BioMotiv and Atomwise announced a strategic collaboration today to integrate AI technology, drug development expertise and an ecosystem of partners for the commercialization of promising early-stage research: bit.ly/35QbSup

BioMotiv today announced a new strategic partnership with Bristol-Myers Squibb to develop novel therapeutics where unmet medical needs remain. Learn more: biomotiv.com

Happy Fourth of July from BioMotiv!

Earlier this week, the @BioMotiv #CLE team took an outing to see the @Indians trounce the Royals! @ProgressiveFans #TribeTown #biotech #FlashbackFriday

@BioMotiv's Kaushik Ghosal provided an overview of #OptiKira's @NIHsbir grant funding at today's @JumpStartInc #StartupScaleup event. @BioECorp @BioOhio @TechOhioGov

Thanks for a great event, @IAmBiotech! See you next year in San Diego! #BIO2019 @BIOConvention

Excited to learn more about the impact of university tech transfer on the US GDP outlined in a new report from @AUTM and @IAmBiotech. #BIO2019

Have you visited the @LifeSciencesPA pavilion at #BIO2019? Be sure to stop by to learn more about the incredible innovations coming out of PA companies, including @BioMotiv! @BIOConvention @IAmBiotech

It was great to visit our friends from @BioOhio on the #Bio2019 exhibit floor! #CLE #biotech @BIOConvention @JobsOhio @johnflewisjr